Incidence Rate of Cardiovascular Events in Rheumatoid Arthritis: An Observational Cohort Study in Saudi Arabia
Laila AlGhalawin,Mukhtar Alomar,Shahad Al Bassam,Aqeelah AlHamdan,Hadeel Anan,Marwah Altaweel,Zainab Alomran,Reem Al khamis,Asma Alqatri,Marwan Alamoudi,Ahmad Alamer
DOI: https://doi.org/10.2147/jmdh.s459555
2024-07-13
Journal of Multidisciplinary Healthcare
Abstract:Laila Saleh AlGhalawin, 1 Mukhtar Alomar, 1 Shahad Al Bassam, 2 Aqeelah Abdullah AlHamdan, 3 Hadeel Anan, 4 Marwah Altaweel, 5 Zainab Abbas Alomran, 6 Reem Al khamis, 7 Asma Ibrahim Alqatri, 8 Marwan M Alamoudi, 9 Ahmad Alamer 10 1 Pharmaceutical Care Affairs, Dammam Medical Complex, Eastern Health Cluster, Dammam, Saudi Arabia; 2 Department of Pharmacy Practice, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia; 3 Pharmacy Department, Al-Mana General Hospital, Dammam, Saudi Arabia; 4 Pharmaceutical Care and Formulary Management Affairs, Eastern Health Cluster, Dammam, Saudi Arabia; 5 Pharmaceutical Care Affairs, Saud AlBabtain Cardiac Center, Eastern Health Cluster, Dammam, Saudi Arabia; 6 Department of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia; 7 Independent Researcher, Dammam, Saudi Arabia; 8 Pharmacy Department, Saudi German Hospital, Dammam, Saudi Arabia; 9 Rheumatology Department, Dammam Medical Complex, Eastern Health Cluster, Dammam, Saudi Arabia; 10 Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia Correspondence: Ahmad Alamer, Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, 16278, P.O. Box: 173, Alkharj, 11942, Saudi Arabia, Email Purpose: Rheumatoid arthritis (RA) doubles the morbidity of cardiovascular disease (CVD) and leads to a 50% increase in mortality compared to the general population. This study aims to estimate the CVD incidence among RA patients in Saudi Arabia (SA), vital for assessing CVD burdens within this group. Patients and Methods: This retrospective study took place at two centers in the Eastern Province of SA, including all adult RA patients who visited the rheumatology clinic from 2016 to 2021 and were prescribed disease-modifying antirheumatic drugs (DMARDs). CVD incidence was determined by the diagnosis of ischemic heart disease (IHD), stroke/transient ischemic attack (TIA), venous thromboembolism (VTE), heart failure (HF), and arrhythmia post-RA diagnosis. Additional data collected included demographics, CVD risk factors, comorbidities, RA-related factors, and medication usage. Results: The study comprised 651 patients, 80.5% of whom were females with an average age of 51. The overall CVD incidence was 11.2 per 1000 person-years, with males experiencing five times more incidents than females. The prevalence of CVD risk factors included 18.7% with hypertension, 7.8% with hyperlipidemia, 18.9% with diabetes, and 42.9% with obesity. Significant predictors of CVD were male gender and RA duration, with adjusted odds ratios (aOR) of 3.17 (95% CI 1.10 to 9.14, P=0.033) and 64.81 (95% CI 3.68 to 1140.6, P=0.004), respectively. Conclusion: This unique study from SA examined the CVD incidence in RA patients, identifying long disease duration and male gender as significant predictors. Effective reduction of CVD risk in RA patients requires aggressive management of modifiable risk factors and regular risk assessments. Keywords: cardio-rheumatology, cardiovascular, arrhythmia, autoimmune arthritis, anti-rheumatic Rheumatoid arthritis (RA) is the most prevalent autoimmune inflammatory arthritis, 1 with an estimated prevalence rate of 460 per 100,000 population between 1980 and 2019. 2 In addition to affecting joints, RA induces a chronic systemic inflammatory state that impacts various tissues and organs, including the cardiovascular system. 3 RA is linked to an increased incidence of cardiovascular disease (CVD), which is the primary cause of death among RA patients, resulting in 50% excess mortality compared to the general population. 4 It is believed that RA patients are at heightened risk for sudden cardiac death due to ischemic and non-ischemic heart disease, and cardiac arrhythmias. 5 The inflammatory nature of RA may contribute to the connection between RA and CVD, due to the increased production of pro-inflammatory substances like erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), interleukins, and tumor necrosis factors. These substances are known to promote endothelial dysfunction, atherosclerosis plaque formation, and cardiac remodeling. 6–9 Previous studies on the relationship between CVD and RA within a Saudi Arabian cohort are scarce. One study from the western region of Saudi Arabia assessed hyperlipidemia prevalence in 180 RA patients, finding that 55.1% had elevated total cholesterol and 55.2% had elevate -Abstract Truncated-
health care sciences & services